• Raia Drogasil posted 2Q26 net income of R$ 440 million, up 9.8% year over year; gross revenue climbed 18.3% to R$ 12.78 billion.
• Adjusted EBITDA (pre-IFRS 16) rose 17.9% to R$ 1.02 billion, holding margin at 8% of gross revenue.
• Digital gross revenue more than doubled, rising 52.2% to R$ 3.9 billion; retail penetration increased 6.1 percentage points to 31%.
• Free cash flow swung to an inflow of R$ 550 million from an outflow a year earlier; financial leverage fell to 0.8x net debt/EBITDA.
• Store base expanded to 3,687 pharmacies with 76 openings and three closures; guidance reiterated for 330-350 gross openings in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Raia Drogasil SA published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.